1. Home
  2. APT vs SCYX Comparison

APT vs SCYX Comparison

Compare APT & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Pro Tech Ltd.

APT

Alpha Pro Tech Ltd.

HOLD

Current Price

$5.59

Market Cap

51.4M

Sector

N/A

ML Signal

HOLD

Logo SCYNEXIS Inc.

SCYX

SCYNEXIS Inc.

HOLD

Current Price

$4.40

Market Cap

44.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APT
SCYX
Founded
1983
1999
Country
Canada
United States
Employees
N/A
29
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.4M
44.0M
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
APT
SCYX
Price
$5.59
$4.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
55.3K
77.8K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.36
EPS
0.07
N/A
Revenue
$59,142,000.00
$257,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$608.78
P/E Ratio
$78.57
N/A
Revenue Growth
2.25
N/A
52 Week Low
$4.34
$0.57
52 Week High
$7.50
$5.62

Technical Indicators

Market Signals
Indicator
APT
SCYX
Relative Strength Index (RSI) 52.11 68.94
Support Level $5.49 $0.67
Resistance Level $5.64 $5.62
Average True Range (ATR) 0.23 0.29
MACD 0.04 -0.08
Stochastic Oscillator 61.97 70.75

Price Performance

Historical Comparison
APT
SCYX

About APT Alpha Pro Tech Ltd.

Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: